OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
September 19, 2023
CDMO will continue to produce commercial antibody cancer drug substance, featuring a new $242 million agreement.
The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
September 18, 2023
A panel at the recent Talk Health event in Philadelphia focused on what success looks like in audio from publisher, vendor, and HCP perspectives.
September 15, 2023
PBM transparency and data reporting requirements are likely to be part of a larger healthcare bill that Congress will work on this fall.
Protective case manufacturer hires James Curleigh, as company prepares to further innovation and expand.
September 14, 2023
Appointment comes amid resignation of Marie-France Tschudin from company executive committee.
Collaboration aims to expedite the transportation of cancer detection radiopharmaceuticals throughout Chile.
Financial commitment is intended to benefit development and commercialization of new products.
September 13, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Organization hires Kala Shankle, who joins the team with supply chain security and drug pricing experience.